
Microfluidic chip screens leukemia drug therapies in children
Engineers and pediatric oncologists at Emory University, Children's Healthcare of Atlanta, and Georgia Tech have developed a diagnostic test that screens cancer drugs directly against patient cells at diagnosis. The platform evaluates how three-drug combinations at varying doses affect live cancer cells, offering immediate functional data from a single sample.
Giovanni Sapere
















